Project Details
Description
A Multicenter, Open-label, Extension Study of the Safety and Tolerability of Sitravatinib Alone or in Combination with Other Anticancer Therapies in Patients with Advanced or Metastatic Solid Malignancies
| Status | Finished |
|---|---|
| Effective start/end date | 6/7/21 → 5/31/26 |
Funding
- MIRATI THERAPEUTICS, INC.
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.